← Back to home

ADVANCED HEPATOCELLULAR CARCINOMA THAT HAS FAILED AT LEAST ONE PRIOR SYSTEMIC THERAPY

Clinical trials for ADVANCED HEPATOCELLULAR CARCINOMA THAT HAS FAILED AT LEAST ONE PRIOR SYSTEMIC THERAPY explained in plain language.

Never miss a new study

Get alerted when new ADVANCED HEPATOCELLULAR CARCINOMA THAT HAS FAILED AT LEAST ONE PRIOR SYSTEMIC THERAPY trials appear

Sign up with your email to follow new studies for ADVANCED HEPATOCELLULAR CARCINOMA THAT HAS FAILED AT LEAST ONE PRIOR SYSTEMIC THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug duo tested for Tough-to-Treat liver cancer

Disease control Ongoing

This study is testing whether combining two drugs, cadonilimab and regorafenib, can help control advanced liver cancer that has continued to grow despite at least one prior treatment. It will involve about 30 adults to see how well the combination works and how safe it is. The ma…

Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA THAT HAS FAILED AT LEAST ONE PRIOR SYSTEMIC THERAPY

Phase: PHASE1 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated Mar 18, 2026 14:40 UTC

ADVANCED HEPATOCELLULAR CARCINOMA THAT HAS FAILED AT LEAST ONE PRIOR SYSTEMIC THERAPY

Get alerted when new ADVANCED HEPATOCELLULAR CARCINOMA THAT HAS FAILED AT LEAST ONE PRIOR SYSTEMIC THERAPY trials appear

New drug duo tested for Tough-to-Treat liver cancer